| Literature DB >> 35072288 |
Habiba A Bham1, Jonathan Denniss1.
Abstract
PURPOSE: Blur is one of the most commonly reported visual symptoms of glaucoma, but it is not directly measured by current clinical tests. We aimed to investigate the effects of glaucoma on detection and discrimination of image blur.Entities:
Keywords: blur; detection; discrimination; glaucoma
Mesh:
Year: 2022 PMID: 35072288 PMCID: PMC9306785 DOI: 10.1111/opo.12947
Source DB: PubMed Journal: Ophthalmic Physiol Opt ISSN: 0275-5408 Impact factor: 3.992
FIGURE 110–2 visual field locations. The circle encompasses the central 12 points used in the visual field criteria to define the two groups of glaucoma participants, with and without central visual field defects
FIGURE 2Two‐interval forced‐choice procedure used to measure contrast detection thresholds. In each trial, stimuli were presented randomly in either interval 1 or 2. Interval duration was 350 ms with an inter‐stimulus interval (ISI) duration of 500 ms. Participants indicated which interval the stimulus appeared in by pressing a key
FIGURE 3Stimulus arrangement for the free viewing, 2‐alternative forced‐choice procedure used to measure thresholds for blur detection (reference blur 0 arcmin) and discrimination (reference blur 1 arcmin). Reference and test stimuli were presented randomly either to the left or right of the centre of screen. Participants were instructed to indicate which of the two stimuli was sharper
Individual visual field summary indices, visual acuity and cataract grading for the tested eye of participants in the glaucoma central visual field (VF) defect group
| Participant | Age (years) | 24–2 MD (dB) | 24–2 PSD (dB) | 24–2 GHT | 10–2 MD (dB) | 10–2 PSD (dB) | BCVA (logMAR) | LOCSIII grading |
|---|---|---|---|---|---|---|---|---|
| 1 | 75 | −2.57 | 6.27 | ONL | −4.71 | 6.59 | 0.12 | Clear IOL |
| 2 | 64 | −5.64 | 7.63 | ONL | −7.23 | 8.77 | 0.10 | NC0.5 NO0.5 C0 P0 |
| 3 | 65 | −2.69 | 10.70 | ONL | −12.51 | 16.37 | 0.00 | NC1 NO1 C0 P0 |
| 4 | 77 | −3.33 | 6.32 | ONL | −6.25 | 10.35 | 0.00 | NC2 NO2 C0 P0 |
| 5 | 61 | −14.95 | 10.43 | ONL | −11.44 | 10.60 | −0.02 | NC2 NO2 C0 P0 |
| 6 | 67 | −8.62 | 10.11 | ONL | −14.92 | 14.97 | 0.10 | NC1.5 NO1.5 C0 P0 |
| 7 | 66 | −1.92 | 5.04 | ONL | −7.54 | 11.09 | 0.08 | NC2 NO2 C0 P0 |
| 8 | 77 | −12.77 | 13.09 | ONL | −11.50 | 13.89 | 0.12 | Clear IOL |
| 9 | 84 | −4.34 | 5.92 | ONL | −5.79 | 8.82 | 0.12 | Clear IOL |
| 10 | 78 | −4.53 | 2.48 | GRS | −3.82 | 1.71 | 0.04 | Clear IOL |
| 11 | 74 | −13.08 | 10.68 | ONL | −5.43 | 3.18 | 0.02 | NC2 NO2 C0 P0 |
| 12 | 76 | −8.00 | 4.25 | ONL | −8.65 | 7.70 | 0.02 | Clear IOL |
| 13 | 64 | −4.50 | 10.44 | ONL | −14.00 | 16.83 | 0.02 | NC1.5 NO1.5 C0 P0 |
| 14 | 70 | −3.21 | 2.48 | ONL | −5.10 | 1.97 | −0.10 | Clear IOL |
| 15 | 69 | −4.83 | 2.72 | BL/GRS | −4.04 | 3.73 | 0.10 | NC1 NO1 C0 P0 |
Abbreviations: BCVA, Best Corrected Visual Acuity; BL, Borderline; GHT, Glaucoma Hemifield Test; GRS, Generalised Reduction of Sensitivity; IOL, intraocular lens; LOCSIII, Lens Opacity Classification System III; MD, Mean Deviation; ONL, Outside Normal Limits; PSD, Pattern Standard Deviation.
Individual visual field summary indices, visual acuity and cataract grading for the tested eye of participants in the glaucoma normal central group
| Participant | Age (y) | 24–2 MD (dB) | 24–2 PSD (dB) | 24–2 GHT | 10–2 MD (dB) | 10–2 PSD (dB) | BCVA (logMAR) | LOCSIII grading |
|---|---|---|---|---|---|---|---|---|
| 1 | 73 | −4.71 | 6.15 | ONL | −3.55 | 1.68 | −0.04 | Clear IOL |
| 2 | 78 | −6.13 | 6.04 | ONL | −3.03 | 1.60 | 0.10 | Clear IOL |
| 3 | 70 | −2.35 | 3.66 | ONL | −0.47 | 1.49 | −0.08 | NC1.5 NO1.5 C0 P0 |
| 4 | 61 | −6.29 | 11.17 | ONL | −9.35 | 15.03 | 0.04 | NC1 NO1 C0 P0 |
| 5 | 70 | −3.01 | 2.20 | ONL | −2.95 | 4.04 | −0.02 | NC1 NO1 C0 P0 |
| 6 | 74 | −1.46 | 2.77 | ONL | −4.72 | 9.26 | 0.06 | Clear IOL |
| 7 | 67 | −5.91 | 6.57 | ONL | −2.49 | 2.33 | 0.06 | NC1 NO1 C0 P0 |
| 8 | 69 | −1.61 | 6.50 | ONL | 0.79 | 1.74 | −0.06 | NC2.5 NO2.5 C0 P0 |
| 9 | 69 | −3.20 | 3.05 | ONL | −1.97 | 2.22 | 0.06 | NC1.5 NO1.5 C0 P0 |
| 10 | 73 | −5.69 | 7.18 | ONL | −2.78 | 1.75 | 0.10 | NC2.5 NO2.5 C0.5 P0.5 |
| 11 | 83 | −3.71 | 2.34 | WNL | −1.57 | 1.34 | 0.12 | Clear IOL |
| 12 | 74 | −5.60 | 10.60 | ONL | −10.02 | 14.32 | 0.10 | Clear IOL |
| 13 | 62 | −4.06 | 8.38 | ONL | −9.59 | 11.47 | 0.10 | NC1 NO1 C0 P0 |
| 14 | 61 | −5.72 | 9.61 | ONL | −2.82 | 7.48 | −0.10 | NC1 NO1 C0 P0 |
| 15 | 69 | −2.70 | 2.23 | BL | −3.73 | 1.92 | 0.08 | NC2 NO2 C0 P0 |
| 16 | 76 | −4.38 | 7.18 | ONL | −1.07 | 1.86 | 0.04 | NC2.5 NO2.5 C0 P0 |
| 17 | 73 | −2.95 | 4.90 | ONL | −1.77 | 1.84 | 0.02 | NC1 NO1 C0 P0 |
Abbreviations as in Table 1.
Abbreviation: WNL, within normal limits.
Number of datasets removed for each experimental condition due to non‐convergent staircases
| Ref Blur 0, Low contrast | Ref Blur 0, High contrast | Ref Blur 1, Low contrast | Ref Blur 1, High contrast | |
|---|---|---|---|---|
| Controls | 3 | 0 | 0 | 1 |
| Glaucoma normal central VF | 0 | 0 | 1 | 0 |
| Glaucoma central VF defect | 0 | 1 | 1 | 0 |
Abbreviation: VF, visual field.
FIGURE 4Contrast detection thresholds for controls (orange circles), glaucoma participants with a central visual field defect (purple triangles), and glaucoma participants without a central visual field defect (blue squares). Thresholds are given as Michelson units converted into percentages (Michelson units × 100). Data shown are mean ± 95% CI (confidence interval)
FIGURE 5Blur detection thresholds (mean ± 95% confidence interval [CI] of the mean) for each group for high (left) and low (right) contrast stimuli. Symbols as in Figure 4
FIGURE 6Group blur discrimination thresholds (mean ± 95% confidence interval [CI] of the mean) for a reference blur of 1 arcmin for high (left) and low (right) contrast stimuli. Symbols as in Figure 4